A novel biosafety level 2 compliant tuberculosis infection model using a ΔleuDΔpanCD double auxotroph of Mycobacterium tuberculosis H37Rv and Galleria mellonella

par Masanori Asai, Yanwen Li, John Spiropoulos, William Cooley, David Everest, Brian D. Robertson, Paul R. Langford, Sandra M. Newton
Publié 2020

Rifampin- or Capreomycin-Induced Remodeling of the <italic toggle="yes">Mycobacterium smegmatis</italic> Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic A...

par DeDe Kwun-Wai Man, Tokuwa Kanno, Giorgia Manzo, Brian D. Robertson, Jenny K. W. Lam, A. James Mason
Publié 2018

A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy

par Komal Umashankar Rao, Domhnall Iain Henderson, Nitya Krishnan, Manoj Puthia, Izabela Glegola-Madejska, Lena Brive, Fanny Bjarnemark, Anna Millqvist Fureby, Karin Hjort, Dan I. Andersson, Erik Tenland, Erik Sturegård, Brian D. Robertson, Gabriela Godaly
Publié 2021